v3.26.1
Segment Reporting (Tables)
 6 Months Ended
Jun. 30, 2026
Segment Reporting [Abstract]  
Schedule of Disaggregation of Income Statement Expenses
This following table presents segment operation results for the three and six months ended June 30, 2026 and 2025:
Three Months Ended
June 30,		Six Months Ended
June 30,
2026202520262025
(in thousands)
Operating expenses:
Research and development - external costs (1)
$208,844 $144,730 $465,276 $248,535 
Research and development - internal costs (2)
59,008 49,449 115,355 93,778 
General and administrative
34,925 32,040 67,996 64,699 
Total operating expenses
$302,777 $226,219 $648,627 $407,012 
Total other income, net
18,475 59,646 43,703 99,721 
Net loss
$284,302 $166,573 $604,924 $307,291 
____________________________________________________________
(1)Research and development - external costs consist primarily of product and clinical development, research, facility, depreciation, professional and consulting services expenses attributed to the research and development departments.
(2)Research and development - internal costs consist of internal employee costs including stock-based compensation expenses.